Ionian Technologies Inc. was a United States Biotechnology Company focused on molecular diagnostics development for the detection of infectious diseases and biothreat agents.

Ionian's proprietary isothermal technology, termed the Nicking Enzyme Amplification Reaction Assay, is claimed to be capable of amplifying extremely low amounts of starting material to easily detectable levels in just a few minutes.

The proprietary technology is based on the very rapid detection of small DNA or RNA fragments generated directly from the target nucleic acid.

Ionian Technologies Inc. describes itself as a private company focused on molecular diagnostics and advanced biomedical research tools based on proprietary isothermal systems for DNA and RNA amplification and detection.

Ionian has made significant efforts for providing rapid and economical systems for third world countries and have received funding from the Bill and Melinda Gates Foundation to achieve these goals.